Retrieve available abstracts of 312 articles: HTML format
Single Articles
January 2025
SHABO I, Midtbo K, Branstrom R, Lindstrom A, et al Monocyte-cancer cell fusion is mediated by phosphatidylserine-CD36 receptor
interaction and induced by ionizing radiation.
PLoS One. 2025;20:e0311027. PubMedAbstract available
WANNUME H, Niyonzima N, Kalungi S, Okuni JB, et al Quantitative expression of estrogen, progesterone and human epidermal growth
factor receptor-2 and their correlation with immunohistochemistry in breast
cancer at Uganda Cancer Institute.
PLoS One. 2025;20:e0311185. PubMedAbstract available
KIM H, Park H, Chun Y, Kim H, et al Prognostic significance of total choline on in-vivo proton MR spectroscopy for
prediction of late recurrence in patients with hormone receptor-positive,
HER2-negative early breast cancer.
PLoS One. 2025;20:e0311012. PubMedAbstract available
TAKANO EA, Jana MK, Lara Gonzalez LE, Pang JB, et al Preliminary characterisation of the spatial immune and vascular environment in
triple negative basal breast carcinomas using multiplex fluorescent
immunohistochemistry.
PLoS One. 2025;20:e0317331. PubMedAbstract available
ALDWOAH K, Louati H, Eljaneid N, Aljaaidi T, et al Fractional and stochastic modeling of breast cancer progression with real data
validation.
PLoS One. 2025;20:e0313676. PubMedAbstract available
WANG X, Leow QHM, Lee HK, Mok CY, et al Healthcare providers' (HCPs) perspectives in initiating discussion on mammogram
screening, and their perceived barriers and enablers to screening in women-A
qualitative study.
PLoS One. 2025;20:e0311999. PubMedAbstract available
KAYA M, Abuaisha A, Suer I, Emiroglu S, et al Let-7b-5p sensitizes breast cancer cells to doxorubicin through Aurora Kinase B.
PLoS One. 2025;20:e0307420. PubMedAbstract available
YU DY, Lee TY, Kim DW, Chang YW, et al Preliminary experience and learning curve of endoscopic nipple-areolar-complex
sparing total mastectomy: A single-center retrospective study.
PLoS One. 2025;20:e0311764. PubMedAbstract available
JENSEN MD, Hansen KM, Siersma V, Brodersen J, et al Mammography screening: Eliciting the voices of informed citizens.
PLoS One. 2025;20:e0317263. PubMedAbstract available
GRASSI M, Tarantino B SEMdag: Fast learning of Directed Acyclic Graphs via node or layer ordering.
PLoS One. 2025;20:e0317283. PubMedAbstract available
ALHAWARRI MB, Al-Thiabat MG, Dubey A, Tufail A, et al Targeting necroptosis in MCF-7 breast cancer cells: In Silico insights into
8,12-dimethoxysanguinarine from Eomecon Chionantha through molecular docking,
dynamics, DFT, and MEP studies.
PLoS One. 2025;20:e0313094. PubMedAbstract available
MALEKI F, Handali S, Rezaei M The role of mitochondrial dysfunction in the cytotoxic synergistic effect of
gemcitabine and arsenic on breast cancer.
PLoS One. 2025;20:e0312424. PubMedAbstract available
Correction: In search of autophagy biomarkers in breast cancer: Receptor status
and drug agnostic transcriptional changes during autophagy flux in cell lines.
PLoS One. 2025;20:e0317835. PubMedAbstract available
ANOSOVA O, Head A, Collins B, Alexiou A, et al Estimating the burden of underdiagnosis within England: A modelling study of
linked primary care data.
PLoS One. 2025;20:e0313877. PubMedAbstract available
AYEBENG C, Okyere J, Okantey C, Addo IY, et al Multifaceted barriers associated with clinical breast examination in sub-Saharan
Africa: A multilevel analytical approach.
PLoS One. 2025;20:e0316800. PubMedAbstract available
HUANG S, Huang M, Long F, Wang F, et al Post-traumatic growth experience of breast cancer patients: A qualitative
systematic review and meta-synthesis.
PLoS One. 2025;20:e0316108. PubMedAbstract available
REAL-PEREZ M, Fernandez-Garcia JC, Gavala-Gonzalez J Effects of a 6-month rowing training program in breast cancer survivors.
PLoS One. 2025;20:e0317118. PubMedAbstract available
HENRY NL, Kidwell KM, Kozar S, Snyder S, et al Self-acupressure for patients with breast cancer experiencing aromatase
inhibitor-associated musculoskeletal symptoms: Protocol for the AcuAIM randomized
pilot trial.
PLoS One. 2025;20:e0311044. PubMedAbstract available
LIU X, Yang T, Yao J Impact of digital breast tomosynthesis on screening performance and interval
cancer rates compared to digital mammography: A meta-analysis.
PLoS One. 2025;20:e0315466. PubMedAbstract available
DEMEKE AD, Deribe B, Girma M, Gizaw M, et al Screening attendance of breast or cervical cancers and its associated factors
among 30-49 year old women in Gedeo zone, South Ethiopia: Cross-sectional study.
PLoS One. 2025;20:e0315891. PubMedAbstract available
UM S, Sopheab H Breast and cervical cancer screening among women at reproductive age in Cambodia:
A secondary analysis of Cambodia Demographic and Health Survey 2022.
PLoS One. 2025;20:e0295881. PubMedAbstract available
ELKAEED EB, Elkady H, Khattab AM, Yousef RG, et al Integrated in silico and in vitro exploration of the anti-VEGFR-2 activities of a
semisynthetic xanthine alkaloid inhibiting breast cancer.
PLoS One. 2025;20:e0316146. PubMedAbstract available
GAO Y, Liang G, Chang C, Pan F, et al Analysis of cervical and breast cancer screening behavior and its influencing
factors among urban and rural women in Beijing.
PLoS One. 2025;20:e0316898. PubMedAbstract available
LI B, Liu J, Zhang Y, Yang W, et al Comparative readability of information on different treatment options for breast
cancer, based on WeChat public accounts.
PLoS One. 2025;20:e0317032. PubMedAbstract available
LIU L, Meng Z, Yan J Efficacy of acupuncture in treating chemotherapy-related cognitive impairment in
breast cancer patients: A systematic review and meta-analysis protocol.
PLoS One. 2025;20:e0318984. PubMedAbstract available
LAI Y, Huang P Machine learning identifies the association between second primary malignancies
and postoperative radiotherapy in young-onset breast cancer patients.
PLoS One. 2025;20:e0316722. PubMedAbstract available
KITAGAWA T Hydrothermal treatment of yeast cell wall generates potent anti-proliferative
agents targeting MCF7 breast cancer cells effectively even under culture
conditions separated by a plastic wall.
PLoS One. 2025;20:e0313379. PubMedAbstract available
NAFIE EHO, Pastori C, Acharya R, Kaviani R, et al Understanding the aliya pulsed electric field dose-response relationship:
Implications for ablation size, thermal load, and immune response in an
orthotopic murine breast cancer model.
PLoS One. 2025;20:e0318440. PubMedAbstract available
OLSSON IM, Dykes C, Ryden L, Olsson-Moller U, et al Experiences of rehabilitation one year after breast cancer diagnosis-A focus
group study from the ReScreen randomized controlled trial.
PLoS One. 2025;20:e0315814. PubMedAbstract available
PARK P, Choi Y, Han N, Park YL, et al Leveraging natural language processing for efficient information extraction from
breast cancer pathology reports: Single-institution study.
PLoS One. 2025;20:e0318726. PubMedAbstract available
DONG J, Lei R, Ma F, Yu L, et al Machine learning-based prediction of distant metastasis risk in invasive ductal
carcinoma of the breast.
PLoS One. 2025;20:e0310410. PubMedAbstract available
KHAN MA, Khan ZA, Husain I, Upadhyay S, et al Effects of pressure on the survival and viability of cancer cells in vitro: An
analytical study.
PLoS One. 2025;20:e0311685. PubMedAbstract available
Retraction: A Bmi1-miRNAs cross-talk modulates chemotherapy response to
5-fluorouracil in breast cancer cells.
PLoS One. 2025;20:e0319490. PubMed
ALI MS Multilevel analysis of undergoing clinical breast examination and its associated
factors among mothers of reproductive age in Kenya: Kenyan Demographic and Health
Survey 2022.
PLoS One. 2025;20:e0319183. PubMedAbstract available
Retraction: BMP9 inhibits proliferation and metastasis of HER2-positive SK-BR-3
breast cancer cells through ERK1/2 and PI3K/AKT pathways.
PLoS One. 2025;20:e0320173. PubMed
MILLER A, De May H, Rou DL, Agarwal JP, et al Understanding the early molecular changes associated with radiation therapy-A
preliminary bulk RNA sequencing study.
PLoS One. 2025;20:e0316443. PubMedAbstract available
STOFFEL ST, Natale C, von Wagner C The impact of temporal framing of breast cancer risk on perceptions of and
motivations to engage with information about early diagnosis: Evidence from an
online experiment.
PLoS One. 2025;20:e0320245. PubMedAbstract available
Retraction: Tanshinone IIA inhibits HIF-1alpha and VEGF expression in breast cancer
cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway.
PLoS One. 2025;20:e0321151. PubMed
NI X, Wang W, Sun H, An R, et al A new marker for predicting sentinel lymph node metastasis in early (cT1-2N0)
breast cancer: Tumor-infiltrating lymphocytes (TILs).
PLoS One. 2025;20:e0320487. PubMedAbstract available
LE MN, Chen D, Smith KA, Tran DD, et al Microfluidic isolation and release of live disseminated breast tumor cells in
bone marrow.
PLoS One. 2025;20:e0319392. PubMedAbstract available
MALLARI MA, Singh A, Shubella J, Khaliq W, et al Cancer screening prevalence and preference among hospitalized women with and
without diabetes mellitus.
PLoS One. 2025;20:e0319681. PubMedAbstract available
RAHMANDOUST M, Abdolrahimi S Introducing carbon quantum dot-Capivasertib drug carrier complex for enhanced
treatment of breast cancer.
PLoS One. 2025;20:e0319206. PubMedAbstract available
CHEN J, He L, Shi Y, Jiao J, et al Effect of opioid-free anesthesia combined with pectoral nerve block on the
quality of recovery in patients after mastectomy: A randomized, controlled trial.
PLoS One. 2025;20:e0320592. PubMedAbstract available
EANES LA, Eldeeb M, Storholt D, Patel YM, et al Naringenin impairs mitochondrial function via ROS to induce apoptosis in
tamoxifen resistant MCF-7 breast cancer cells.
PLoS One. 2025;20:e0320020. PubMedAbstract available
JAVRUSHYAN H, Ginovyan M, Harutyunyan T, Gevorgyan S, et al Elucidating the impact of Hypericum alpestre extract and L-NAME on the PI3K/Akt
signaling pathway in A549 lung adenocarcinoma and MDA-MB-231 triple-negative
breast cancer cells.
PLoS One. 2025;20:e0303736. PubMedAbstract available
CHEN P, Qiao D, Xiao L, Deng G, et al Cost-effectiveness analysis of toripalimab combined with nab-paclitaxel as a
first-line treatment for advanced TNBC in the US.
PLoS One. 2025;20:e0320727. PubMedAbstract available
ABUHAY HW, Alemu GG, Aweke MN, Alemu TG, et al Clinical breast cancer screening uptake and associated factors among reproductive
age women in Kenya: further analysis of Kenyan Demographic and Health Survey
2022.
PLoS One. 2025;20:e0320730. PubMedAbstract available
EL-TANANI M, Satyam SM, Rabbani SA, Obeidat RM, et al Decoding oncogenic secrets of regulator of chromosome condensation 1: A
breakthrough mechanistic evidence from breast and lung cancer models.
PLoS One. 2025;20:e0319748. PubMedAbstract available
SAGHAZADEH A Study of heterogeneity in immune responses to exposure in breast cancer: A
protocol for a systematic review.
PLoS One. 2025;20:e0320498. PubMedAbstract available
GODINA C, Khazaei S, Belting M, Vallon-Christersson J, et al Correction: High Caveolin-1 mRNA expression in triple-negative breast cancer is
associated with an aggressive tumor microenvironment, chemoresistance, and poor
clinical outcome.
PLoS One. 2025;20:e0322403. PubMedAbstract available
MAHAR B, Osman MB, Ahmad Fauzi FB Effectiveness of theory-based breast self-examination intervention for breast
cancer prevention among female college teachers in Pakistan: A cluster randomized
controlled trial study protocol.
PLoS One. 2025;20:e0321634. PubMedAbstract available
SINGH A, Dwivedi RK, Singh VK, Sharma M, et al Modeling and simulation of an effectual triangular slotted UWB flexible antenna
for breast cancer detection and healthcare monitoring.
PLoS One. 2025;20:e0320806. PubMedAbstract available
ZHU G, Dong Y, Zhu R, Tan Y, et al Dynamic contrast-enhanced magnetic resonance imaging parameters combined with
diffusion-weighted imaging for discriminating malignant lesions, molecular
subtypes, and pathological grades in invasive ductal carcinoma patients.
PLoS One. 2025;20:e0320240. PubMedAbstract available
KIVUYO N, Akoko L, Mutajwaha JOG, Haule C, et al Dismal pathological response to neoadjuvant chemotherapy in stage III breast
cancer patients in Tanzania: A retrospective review.
PLoS One. 2025;20:e0321187. PubMedAbstract available
BAIDOO TG, Rodrigo H Data-driven survival modeling for breast cancer prognostics: A comparative study
with machine learning and traditional survival modeling methods.
PLoS One. 2025;20:e0318167. PubMedAbstract available
ENEH S, Hartikainen JM, Heikkinen S, Sironen R, et al High expression of miR-7974 predicts poor prognosis and is associated with
autophagy in estrogen receptor-positive breast cancer.
PLoS One. 2025;20:e0322179. PubMedAbstract available
YE X, Xu T, Cao J, Li G, et al Knowledge, attitude, and practice toward genetic testing in breast cancer
patients in China.
PLoS One. 2025;20:e0322526. PubMedAbstract available
MIRZAEI Y, Huffel M, McCann S, Bannach-Brown A, et al Animal models in preclinical metastatic breast cancer immunotherapy research: A
systematic review and meta-analysis of efficacy outcomes.
PLoS One. 2025;20:e0322876. PubMedAbstract available
MOHAMMAD HUSSIN N, Nik Jaafar NR, Idris IB, Mohammed Nawi A, et al Evaluating the effects of e-health interventions on mental health outcomes in
individuals with breast cancer: A systematic review.
PLoS One. 2025;20:e0321495. PubMedAbstract available
RAMLI HAMID MT, Ab Mumin N, Abdul Hamid S, Mohd Ariffin N, et al Comparative analysis of diagnostic performance in mammography: A reader study on
the impact of AI assistance.
PLoS One. 2025;20:e0322925. PubMedAbstract available
YANG S, Cheng M, Zhang S, Wang H, et al DNMT3A facilitates breast cancer progression via regulating ADAMTS8 mediated
EGFR-MEK-ERK activation.
PLoS One. 2025;20:e0321889. PubMedAbstract available
PRAJOKO YW, Heriyanto DS, Dirja BT, Susanto S, et al High frequency of the PIK3CA H1047L mutation in Indonesian breast cancer across
molecular subtypes.
PLoS One. 2025;20:e0322154. PubMedAbstract available
Retraction: Response of breast cancer cells and cancer stem cells to metformin
and hyperthermia alone or combined.
PLoS One. 2025;20:e0323982. PubMed
DOUGLAS CM, Newell M, Goruk S, Courneya KS, et al Exploratory outcomes of the DHA WIN randomized controlled trial: Supplementing
women with docosahexaenoic acid did not reduce the impact of neoadjuvant breast
cancer chemotherapy on quality of life or exercise behaviour.
PLoS One. 2025;20:e0322178. PubMedAbstract available
RABBANI B, Tanu SG, Ramanto KN, Audrienna J, et al A combined risk model shows viability for personalized breast cancer risk
assessment in the Indonesian population: A case/control study.
PLoS One. 2025;20:e0321545. PubMedAbstract available
KHOSROWZADEH N, Saini AS, Samimi K, Chambers K, et al Disparities in physician compensation for breast and prostate cancer operations.
PLoS One. 2025;20:e0323892. PubMedAbstract available
WU WP, Lin J, Huang YL, Chen ST, et al Magnetic resonance imaging characteristics and survival outcomes of metaplastic
breast carcinoma.
PLoS One. 2025;20:e0323541. PubMedAbstract available
AZMI MB, Yu H, Sohail A, Asif U, et al In silico analysis to explore the therapeutic potential of propolis-derived small
molecules as matriptase inhibitors to suppress breast cancer growth and
metastasis.
PLoS One. 2025;20:e0321687. PubMedAbstract available
PRADO-CELIS LP, Zamora-Cardenas R, Alamilla J, Sanchez-Pastor EA, et al Nucleolar sequestration of cannabinoid type-2 receptors in triple-negative breast
cancer cells.
PLoS One. 2025;20:e0323554. PubMedAbstract available
KINTEH B, Jitteh F, Badjie M, Barrow A, et al Exploring breast cancer awareness and screening practices amongst rural women in
The Gambia: Community-based cross-sectional study.
PLoS One. 2025;20:e0307785. PubMedAbstract available
Correction: Retraction: Tanshinone IIA Inhibits HIF-1alpha and VEGF Expression in
Breast Cancer Cells via mTOR/p70S6K/RPS6/4E-BP1 Signaling Pathway.
PLoS One. 2025;20:e0324274. PubMedAbstract available
CHEN C, Gao D, Yue H, Wang H, et al Predicting breast cancer prognosis based on a novel pathomics model through CHEK1
expression analysis using machine learning algorithms.
PLoS One. 2025;20:e0321717. PubMedAbstract available
DANISH F A design-based framework for optimal stratification using super-population models
with application on real data set of breast cancer.
PLoS One. 2025;20:e0323619. PubMedAbstract available
DINKEL Z, Baker A, Akins A, King KL, et al Collagen architecture in triple negative breast cancer.
PLoS One. 2025;20:e0324655. PubMedAbstract available
PUN Z, Xue Q, Zhang Y Enhancing ERalpha-targeted compound efficacy in breast cancer threapy with
ExplainableAI and GeneticAlgorithm.
PLoS One. 2025;20:e0319673. PubMedAbstract available
FANG W, Tang S, Yan D, Dai X, et al Breast cancer pathology image recognition based on convolutional neural network.
PLoS One. 2025;20:e0311728. PubMedAbstract available
KHODADADI H, Nazem S Improving cancer detection through computer-aided diagnosis: A comprehensive
analysis of nonlinear and texture features in breast thermograms.
PLoS One. 2025;20:e0322934. PubMedAbstract available
ABUBAKARI AK, Gross J, Adusei-Poku E Factors influencing clinical breast cancer screening: A cross-sectional study
among Islamic women in Kumasi Metropolis of Ghana.
PLoS One. 2025;20:e0320726. PubMedAbstract available
RIOKI JN, Mweu M, Rogena E, Songok EM, et al Factors associated with breast lesions among women attending select teaching and
referral health facilities in Kenya: A cross-sectional study.
PLoS One. 2025;20:e0309182. PubMedAbstract available
MARGULIES BS, Likhitpanichkul M, Tripathy D Reshaping the landscape of locoregional treatments for breast cancer liver
metastases: A novel, intratumoral, p21-targeted percutaneous therapy increases
survival in BALB/c mice inoculated with 4T1 triple negative breast cancer cells
in the liver.
PLoS One. 2025;20:e0323621. PubMedAbstract available
WELLER SC, Pappadis MR, Krishnan S, Stearnes MR, et al Understanding motivations of older women to continue or discontinue breast cancer
screening.
PLoS One. 2025;20:e0319141. PubMedAbstract available
ISSA E, Lahoud R, Abi-Gerges A, Salameh P, et al Breast cancer screening practices during a multifaceted crisis: Data from
Lebanon.
PLoS One. 2025;20:e0325604. PubMedAbstract available
HOU PH, Chang GR, Chao YT, Chang YT, et al Aripiprazole use and lowering the risk of breast cancer in patient with
schizophrenia in a national cohort study.
PLoS One. 2025;20:e0324257. PubMed
LOGANATHAN T, Doss C GP Gut microbiota and its influence on the Gut-Brain axis in comparison with
chemotherapy patients and cancer-free control data in Breast cancer-A
computational perspective.
PLoS One. 2025;20:e0324742. PubMedAbstract available
WANG T, Zang B, Kong C, Li Y, et al Intelligent and precise auxiliary diagnosis of breast tumors using deep learning
and radiomics.
PLoS One. 2025;20:e0320732. PubMedAbstract available
POPIC D, Marinovich ML, Houssami N, Hall J, et al How should artificial intelligence be used in breast screening? Women's reasoning
about workflow options.
PLoS One. 2025;20:e0323528. PubMedAbstract available
GROSSE C, Noack P, Grosse A, Schwarz HK, et al Prognostic impact of HER2-low expression in triple-negative breast cancer of
high-grade special histological type and no special type.
PLoS One. 2025;20:e0325715. PubMedAbstract available
KIM A, Yi C, Ji M, Hwang UJ, et al Pectoralis minor length index at 1 month postoperative can predict homolateral
neuropathic pain 4 months after mastectomy with lymph node resection.
PLoS One. 2025;20:e0326119. PubMedAbstract available
FATIMA A, Khan MU, Ibrahim S, Khurram I, et al Multiscale computational evaluation of Vitex trifolia phytochemicals as VEGFR2
inhibitors for targeted breast cancer therapy.
PLoS One. 2025;20:e0325255. PubMedAbstract available
ARAFAT HM, Al-Astani TAD, Shafii N, Muhamad R, et al Impact of IGFBP-3 A-202C genetic variant on breast cancer susceptibility and
serum biomarkers (IGFBP-3 and IGF-1) in Palestinian women.
PLoS One. 2025;20:e0325289. PubMedAbstract available
SHAON MA, Ansari F, Mahmud Z, Tamanna S, et al Aldo-keto reductase family 1 member C3 (AKR1C3) gene polymorphism (rs12529) is
associated with breast cancer in Bangladeshi population: A case-control study and
computational investigation.
PLoS One. 2025;20:e0318079. PubMedAbstract available
MATUSIN SNI, Mumin N, Zainal Abidin H, Mohd Jaya FN, et al Prevalence and spectrum of germline BRCA1 and BRCA2 mutations in multiethnic
cohort of breast cancer patients in Brunei Darussalam.
PLoS One. 2025;20:e0312635. PubMedAbstract available
AHMED KA, Humaira I, Khan AR, Hasan MS, et al Advancing breast cancer prediction: Comparative analysis of ML models and deep
learning-based multi-model ensembles on original and synthetic datasets.
PLoS One. 2025;20:e0326221. PubMedAbstract available
FAN YC, Lin SC, Lai PJ, Lai PC, et al A psychiatric medication, clozapine, induces autophagy and apoptosis in breast
cancer cells through reactive oxygen species.
PLoS One. 2025;20:e0326224. PubMedAbstract available
Retraction: Selective inhibition of carbonic anhydrase IX over carbonic anhydrase
XII in breast cancer cells using benzene sulfonamides: Disconnect between
activity and growth inhibition.
PLoS One. 2025;20:e0326621. PubMed
LARBI A, Nyarko E, Iddi S Evaluation of optimal strategies for breast cancer screening in Ghana: A
simulation study based on a continuous tumor growth model.
PLoS One. 2025;20:e0323485. PubMedAbstract available
HUTCHISON RE, Smith S, Caudell C, Biddle S, et al Effects of chemotherapy on skeletal muscle mitochondrial oxidative capacity using
near-infrared spectroscopy (NIRS): Protocol paper for an observational mixed
model repeated measures design in patients with breast and gynecological cancer.
PLoS One. 2025;20:e0315351. PubMedAbstract available
UNLU YAZICI M, Marron JS, Bakir-Gungor B, Zou F, et al 3Mont: A multi-omics integrative tool for breast cancer subtype stratification.
PLoS One. 2025;20:e0326154. PubMedAbstract available
RUJIMONGKON K, Adchariyasakulchai P, Meeprasertskul P, Ketchart W, et al Ivermectin inhibits epithelial-to-mesenchymal transition via Wnt signaling in
endocrine-resistant breast cancer cells.
PLoS One. 2025;20:e0326742. PubMedAbstract available
MOFFETT L, Barnett AJ, Donnelly J, Schwartz FR, et al Multi-site validation of an interpretable model to analyze breast masses.
PLoS One. 2025;20:e0320091. PubMedAbstract available
YING J, Cattell R, Huang C Cross-field strength and multi-vendor reliability of MagDensity for MRI-based
quantitative breast density analysis.
PLoS One. 2025;20:e0316076. PubMedAbstract available
BROWNSON-SMITH R, Carr J, Fox KT, Orange ST, et al The test-retest reliability of the H-Reflex and swaymeter in women aged 30-65
years.
PLoS One. 2025;20:e0314437. PubMedAbstract available
NAMBA-BANDO MDMY, Contreras-Yanez I, Tenorio-Torres JA, Pascual-Ramos V, et al Futility in healthcare among Mexican female patients with breast cancer in
advanced stage: The patient perspective.
PLoS One. 2025;20:e0326332. PubMedAbstract available
ALSHAREEDA AT, Albarakati N, Alshawakir Y, Alghuwainem A, et al Improving the robustness and efficiency of cell sheet protocol for breast cancer
induction in animal model: A Geltrex plus Gelatin approach.
PLoS One. 2025;20:e0326456. PubMedAbstract available
WAKS-SERRA MV, Vera DA, Carbone NA, Garcia HA, et al Solid breast tumors phantom emulating oxy and deoxyhemoglobin concentrations for
near infrared imaging.
PLoS One. 2025;20:e0325768. PubMedAbstract available
JAHAN R, Bhuiyan AKMMR, Alam A, Chowdhury MK, et al Outcomes of complex decongestive therapy in managing upper limb lymphedema in
female breast cancer patients at a palliative care unit of a tertiary care
hospital in Bangladesh.
PLoS One. 2025;20:e0326040. PubMedAbstract available
NDJENGUE BENGONE BC, Toniolo J, Filankembo Kava AC, Ngoungou EB, et al Psychological repercussions of breast or uterine cervical cancer disclosure to
women in Gabon.
PLoS One. 2025;20:e0326378. PubMedAbstract available
MSENGA U, Ambikile JS, Buluba SE Prevalence of anxiety and depression symptoms and associated factors among women
diagnosed with breast cancer: A cross-sectional study at Ocean Road Cancer
Institute in Dar es Salaam-Tanzania.
PLoS One. 2025;20:e0326749. PubMedAbstract available
Expression of Concern: Differential expression and function of CAIX and CAXII in
breast cancer: A comparison between tumorgraft models and cells.
PLoS One. 2025;20:e0327518. PubMed
ZAKI RM, Aldosari BN, Alkharashi LA, Alsalhi A, et al Fabrication and appraisal of axitinib loaded PEGylated spanlastics against MCF- 7
and OV- 2774 cell lines using molecular docking methods and in-vitro study.
PLoS One. 2025;20:e0325055. PubMedAbstract available
DWAIRY M, Yehya A, Mohammad FM, Alzoubi H, et al Losartan as a mechanotherapeutic adjuvant: Remodeling the breast tumor
microenvironment to improve treatment efficacy.
PLoS One. 2025;20:e0328196. PubMedAbstract available
AHMED SF, Hossain MS, Mondal A, Shahariar M, et al In silico identification of promising PD-L1 inhibitors from selected indian
medicinal plants for treatment of triple negative breast cancer.
PLoS One. 2025;20:e0327475. PubMedAbstract available
SCERRI J, Agius J, Galea M Emergence of a new me: Experiences of women diagnosed with HER2-positive breast
cancer.
PLoS One. 2025;20:e0325080. PubMedAbstract available
ZAKI RM, Aldosari BN, Alkharashi LA, Alsalhi A, et al Fabrication and appraisal of targeted axitinib loaded bilosomes for the enhanced
breast and ovarian anticancer activity.
PLoS One. 2025;20:e0325511. PubMedAbstract available
KLDIASHVILI E, Abiatari I, Kekelia E, Iordanishvili S, et al SOX2, PIWI proteins, and MALAT1 - plasma-based emerging biomarkers for cancer
detection and monitoring.
PLoS One. 2025;20:e0328557. PubMedAbstract available
VUKEA N, Oderinlo O, Tukulula M, Khanye SD, et al Ferrocene thiazolidine-2,4-dione derivatives cause DNA damage and interfere with
DNA repair in triple-negative breast cancer cells.
PLoS One. 2025;20:e0328155. PubMedAbstract available
HOIBO M, Pedersen A, Dale VG, Berget SM, et al Immunohistochemistry guided segmentation of benign epithelial cells, in situ
lesions, and invasive epithelial cells in breast cancer slides.
PLoS One. 2025;20:e0328033. PubMedAbstract available
PEREIRA SAP, Vesin J, Chambon M, Turcatti G, et al Identification of glutathione transferase (GST P1) inhibitors via a
high-throughput screening assay and implications as alternative treatment options
for breast cancers.
PLoS One. 2025;20:e0319904. PubMedAbstract available
ROSTAMI Z, Mukund K, Masnadi-Shirazi M, Subramaniam S, et al An autoencoder learning method for predicting breast cancer subtypes.
PLoS One. 2025;20:e0327773. PubMedAbstract available
KRETZMANN HG, Adeniyi OV Clinicopathological and molecular subtypes of breast cancer in the Eastern Cape,
South Africa: A two-year retrospective study.
PLoS One. 2025;20:e0325387. PubMedAbstract available
PARKER G, Hogarth S, Fishman J, Miller FA, et al Prognosis, treatment decision-making and value: A qualitative exploration of the
emerging role of breast cancer prognostic assays.
PLoS One. 2025;20:e0322509. PubMedAbstract available
MOHD ZAIN AH, Mohd Isa SA, Che Jalil NA, Mohd Hairon S, et al Modification of the nuclear pleomorphism score in the Modified Bloom-Richardson
grading for invasive breast cancer.
PLoS One. 2025;20:e0327860. PubMedAbstract available
BOGALE M, Mengstie TA, Tadesse E, Dejenie TA, et al Association of FGF Receptor-2rs2981578 SNP with breast cancer in women at the
University of Gondar Comprehensive Specialized Hospital, Ethiopia.
PLoS One. 2025;20:e0327034. PubMedAbstract available
WATABE S, Watanabe T, Yada S, Aramaki E, et al Correction: Exploring a method for extracting concerns of multiple breast cancer
patients in the domain of patient narratives using BERT and its optimization by
domain adaptation using masked language modeling.
PLoS One. 2025;20:e0329664. PubMedAbstract available
LEE J, Foroughi M, Kung V, Ali R, et al Molecular and morphological alterations in breast tissue of transgender patients
undergoing dihydrotestosterone therapy.
PLoS One. 2025;20:e0325034. PubMedAbstract available
LIU X, Wu H, Zhang S, Zhu Z, et al Higher red cell distribution width (RDW) is associated with increased all-cause
and cardiovascular mortality in patients with breast cancer: A retrospective
analysis of NHANES data (1999-2018).
PLoS One. 2025;20:e0328680. PubMedAbstract available
LI X, Liu Y, Wang Z, Bu X, et al Response Gene to Complement 32 promotes cell proliferation and tamoxifen
resistance in breast cancer via elevated FoxM1 expression.
PLoS One. 2025;20:e0328698. PubMedAbstract available
DANIELS J, Kyei KA, Walubo R, Nyantakyi AY, et al Prevalence and clinicopathological characteristics of breast cancer patients with
brain metastases in Ghana: A single-center cross-sectional study.
PLoS One. 2025;20:e0329308. PubMedAbstract available
HELU A, Samawi H Assessing uncertainty: A study of entropy measures for Burr XII distribution
under progressive Type-II censoring.
PLoS One. 2025;20:e0329086. PubMedAbstract available
AGIDE FD, Garmaroudi G, Sadeghi R, Shakibazadeh E, et al Designing and evaluation of the effect of community-based intervention on breast
self-examination among reproductive-aged women in Ethiopia: A Cluster Randomized
Controlled Trial.
PLoS One. 2025;20:e0329839. PubMedAbstract available
LU X, Wei C, Li C, Liu J, et al Do skin bacteriostatic agents reduce acute radiodermatitis in breast cancer
patients? A prospective interventional study.
PLoS One. 2025;20:e0328536. PubMedAbstract available
TSAI MH, Vo JB, Moore JX, Ramin C, et al Mediating effects of mental and physical health on the association between
chronic disease conditions and colorectal cancer screening utilization among
breast cancer survivors.
PLoS One. 2025;20:e0328353. PubMedAbstract available
YANG C, Liu Y, Gai L, Zhang Z, et al Artesunate regulates malignant progression of breast cancer cells via lncRNA
TUG1/miR-145-5p/HOXA5 axis.
PLoS One. 2025;20:e0329490. PubMedAbstract available
VEZZANI F, Cabieses B, Obach A, Torrealba S, et al Unmet supportive care needs of young women with breast cancer in Chile during
follow-up stage after treatment: A qualitative study.
PLoS One. 2025;20:e0330166. PubMedAbstract available
KHATRI RB, Endalamaw A, Darssan D, Assefa Y, et al A scoping review of the levels, implementation strategies, enablers, and barriers
to cervical, breast, and colorectal cancer screening among migrant populations in
selected English-speaking high-income countries.
PLoS One. 2025;20:e0329854. PubMedAbstract available
SALAR-ANDREU C, Montero-Navarro S, Lozano-Rubio A, Del Rio-Medina S, et al Effectiveness of radiofrequency and exercise-based rehabilitation on symptoms
associated with pelvic floor dysfunction in breast cancer patients: A study
protocol.
PLoS One. 2025;20:e0330156. PubMedAbstract available
ALOMAIRY NA The impact of breast cancer awareness campaigns on the knowledge, attitudes, and
practices of breast cancer screening among Saudi female employees.
PLoS One. 2025;20:e0331765. PubMedAbstract available
KONAKA Y, Ueda T, Inamori R, Sato J, et al Breast cancer classification based on the integration of diagnostic algorithms
for calcifications and masses using a mixture of experts.
PLoS One. 2025;20:e0331017. PubMedAbstract available
XIONG J, Zhang D, Yuan Y, Quan C, et al Association between Systemic Immune-Inflammation Index and female breast cancer
based on NHANES data (2001-2018): A cross-sectional study.
PLoS One. 2025;20:e0330571. PubMedAbstract available
JASSIM GHRABAT MJ, Ghaib AA, Al-Hossenat A, Abduljabbar ZA, et al Effective SMOTE boost with deep learning for IDC identification in whole-slide
images.
PLoS One. 2025;20:e0329078. PubMedAbstract available
LIAO Y, Mohd Hairon S, Majdi Yaacob N, Alina Tengku Ismail T, et al Psychometric validation of a culturally adapted health belief model scale for
breast cancer screening in Chinese women.
PLoS One. 2025;20:e0331279. PubMedAbstract available
ARIK A, Cairns AJG, Streftaris G Cancer disparities: Projection, COVID-19, and scenario-based diagnosis delay
impact.
PLoS One. 2025;20:e0330752. PubMedAbstract available
RAHIMZADEH S, Bentham J, Burczynska B, Farzadfar F, et al Spatiotemporal disparity of breast cancer incidence in Iranian female populations
at the district level from 2000 to 2021: Bayesian disease mapping.
PLoS One. 2025;20:e0330017. PubMedAbstract available
JIA C, Yang F Integrative network toxicology and molecular docking reveal 4-Nonylphenol's
multifaceted mechanisms in breast cancer pathogenesis.
PLoS One. 2025;20:e0331944. PubMedAbstract available
BRAUN T, Huesmann S, Pfister K, Friedl TWP, et al The SURVIVE study (NCT05658172): Bringing breast cancer aftercare to the
21stcentury: Study protocol of a Phase III clinical trial comparing liquid biopsy
guided vs. Standard of care surveillance for intermediate to high-risk breast
cancer survivors.
PLoS One. 2025;20:e0331203. PubMedAbstract available
YUN H, Noh S, Cho H, Ko EY, et al AI-Driven quality assurance in mammography: Enhancing quality control efficiency
through automated phantom image evaluation in South Korea.
PLoS One. 2025;20:e0330091. PubMedAbstract available
JAFRIN S, Aziz MA, Barek MA, Reza MS, et al Association of missense variant DCLRE1B rs3761936 with breast and cervical cancer
risk-A case-control study.
PLoS One. 2025;20:e0331492. PubMedAbstract available
RAMZAN R, Bukhari SA, Rasul A Identification of silibinin and isotretinoin as potent up-regulators of sFRP4
(Wnt antagonist): In silico prediction and in vitro validation in breast cancer.
PLoS One. 2025;20:e0331735. PubMedAbstract available
PRADO SOUSA AC, Duran-Prado M, Villar M, Gonzalez-Garcia A, et al Tick saliva protein fraction inhibits breast cancer by decreasing cell viability
and promoting apoptosis in vitro.
PLoS One. 2025;20:e0331779. PubMedAbstract available
HUNDLEY WW, O'Connell NS, Kirkman DL, Olson KC, et al Statins to reduce renal sinus fat among breast cancer patients undergoing
anthracycline-based chemotherapy: A substudy of PREVENT-WF-98213.
PLoS One. 2025;20:e0318017. PubMedAbstract available
ABDEL-HAMID L, Yogarajah P, Tealab SHA Lightweight deep models based on domain adaptation and network pruning for breast
cancer HER2 scoring: IHC vs. H&E histopathological images.
PLoS One. 2025;20:e0332362. PubMedAbstract available
HERNANDEZ N, Pakarinen T, Salminen A, Castro SL, et al A systematic approach to study the effects of acquisition parameters and
biological factors on computerized mammography analysis using ex vivo human
tissue: A protocol description.
PLoS One. 2025;20:e0321658. PubMedAbstract available
TUNA BG, Keles NA, Cicekdal MB, Dogan S, et al Distinct transcriptomic effects of intermittent and chronic caloric restriction
in mammary fat pad of a breast cancer mouse model.
PLoS One. 2025;20:e0331898. PubMedAbstract available
SOETOMO SA, Sharp MF, Crismani W Differential PARP inhibitor responses in BRCA1-deficient and resistant cells in
competitive co-culture.
PLoS One. 2025;20:e0332860. PubMedAbstract available
GUZMAN-LORITE M, Munoz-Moreno L, Marina ML, Carmena MJ, et al In vitro and in vivo approaches demonstrating the antiproliferative activity of
pomegranate seed proteins and peptides on breast cancer.
PLoS One. 2025;20:e0330895. PubMedAbstract available
January 2024
KUO ET, Kuo C, Lin CL Inhaled anesthesia associated with reduced mortality in patients with stage III
breast cancer: A population-based study.
PLoS One. 2024;19:e0289519. PubMedAbstract available
NYAMHANGA T, Eustace RW, Makoye JP, Mutalemwa K, et al Multi-level barriers to early detection of breast cancer among rural midlife
women in Tanzania: A qualitative case study.
PLoS One. 2024;19:e0297798. PubMedAbstract available
MILLER JL, Reddy A, Harman RM, Van de Walle GR, et al A xenotransplantation mouse model to study physiology of the mammary gland from
large mammals.
PLoS One. 2024;19:e0298390. PubMedAbstract available
XIA Q, Shen J, Wang Q, Chen R, et al Cuproptosis-associated ncRNAs predict breast cancer subtypes.
PLoS One. 2024;19:e0299138. PubMedAbstract available
BAKER R, Dell'Acqua G, Richards A, Thornton MJ, et al Nutraceuticals known to promote hair growth do not interfere with the inhibitory
action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines.
PLoS One. 2024;19:e0297080. PubMedAbstract available
WIRANATA JA, Hutajulu SH, Astari YK, Leo B, et al Patient-reported outcomes and symptom clusters pattern of chemotherapy-induced
toxicity in patients with early breast cancer.
PLoS One. 2024;19:e0298928. PubMedAbstract available
TAOMA K, Ruengjitchatchawalya M, Liangruksa M, Laomettachit T, et al Boolean modeling of breast cancer signaling pathways uncovers mechanisms of drug
synergy.
PLoS One. 2024;19:e0298788. PubMedAbstract available
ABDUL REHMAN M, Tahir E, Ghulam Hussain H, Khalid A, et al Awareness regarding breast cancer amongst women in Pakistan: A systematic review
and meta-analysis.
PLoS One. 2024;19:e0298275. PubMedAbstract available
WAHLSTROM E, Audisio RA, Selvaggi G Aspects to consider regarding breast cancer risk in trans men: A systematic
review and risk management approach.
PLoS One. 2024;19:e0299333. PubMedAbstract available
KESSLER LG, Comstock B, Aiello Bowles EJ, Mou J, et al Protocol to measure validity and reliability of colorectal, breast, cervical and
lung cancer screening questions from the 2021 National Health Interview Survey:
Methodology and design.
PLoS One. 2024;19:e0297773. PubMedAbstract available
NGUYEN AQ, Tran OTM, Nguyen PK, Nguyen HT, et al Cost-effectiveness of one-year adjuvant trastuzumab therapy in treatment for
early-stage breast cancer patients with HER2+ in Vietnam.
PLoS One. 2024;19:e0300474. PubMedAbstract available
NORTHGRAVES M, Cohen J, Harvey J, Huang C, et al A randomised controlled trial of Pre-Operative Oncotype DX testing in early-stage
breast cancer (PRE-DX study) - Study protocol.
PLoS One. 2024;19:e0300339. PubMedAbstract available
ZHU JJ, Huang FY, Chen H, Zhang YL, et al Autocrine phosphatase PDP2 inhibits ferroptosis by dephosphorylating ACSL4 in the
Luminal A Breast Cancer.
PLoS One. 2024;19:e0299571. PubMedAbstract available
BELACHEW EB, Desta AF, Mulu A, Deneke DB, et al High rate of high-risk human papillomavirus among benign and breast cancer
patients in Ethiopia.
PLoS One. 2024;19:e0298583. PubMedAbstract available
OTTO AK, Prinsloo S, Natori A, Wagner RW, et al Impact of COVID-19-related experiences on health-related quality of life in
cancer survivors in the United States.
PLoS One. 2024;19:e0297077. PubMedAbstract available
NIU X, Wang J, Liu J, Yu Q, et al 17beta-Estradiol promotes metastasis in triple-negative breast cancer through the
Calpain/YAP/beta-catenin signaling axis.
PLoS One. 2024;19:e0298184. PubMedAbstract available
EBRAHIMPOUR-KOUJAN S, Benisi-Kohansal S, Azadbakht L, Fallah M, et al Adherence to HEI-2010 and odds of breast cancer according to the menopause
status: Evidence from Middle Eastern Country.
PLoS One. 2024;19:e0300986. PubMedAbstract available
DEMEKE T, Hailemariam D, Santos P, Seife E, et al Willingness and ability to pay for breast cancer treatment among patients from
Addis Ababa, Ethiopia: A cross-sectional study.
PLoS One. 2024;19:e0300631. PubMedAbstract available
RAGHURAM GV, Pal K, Sriram G, Khan A, et al Correction: Therapeutic interventions on human breast cancer xenografts promote
systemic dissemination of oncogenes.
PLoS One. 2024;19:e0301650. PubMedAbstract available
Retraction: Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal
Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC)
Subpopulation Enriched from Breast Cancer Cells.
PLoS One. 2024;19:e0300804. PubMed
KANG ES, Lim YC, Jang BH, Lee YJ, et al Changes in lymph node surgery in breast cancer and preoperative drug prescription
analysis for postoperative pain management: A retrospective, cross-sectional
study.
PLoS One. 2024;19:e0298270. PubMedAbstract available
FONSECA-ALVES CE, Leis-Filho AF, Lacerda ZA, de Faria Lainetti P, et al Lapatinib antitumor effect is associated with PI3K and MAPK pathway: An analysis
in human and canine prostate cancer cells.
PLoS One. 2024;19:e0297043. PubMedAbstract available
ZHU K, Sui Y, Zhu M, Gao Y, et al Development and validation of a nomogram for predicting lymph node metastasis in
ductal carcinoma in situ with microinvasion: A SEER population-based study.
PLoS One. 2024;19:e0301057. PubMedAbstract available
ALHASSAN AM An improved breast cancer classification with hybrid chaotic sand cat and Remora
Optimization feature selection algorithm.
PLoS One. 2024;19:e0300622. PubMedAbstract available
SLOJEWSKA K, Galbarczyk A, Klimek M, Tubek-Krokosz A, et al Higher number of steps is related to lower endogenous progesterone but not
estradiol levels in women.
PLoS One. 2024;19:e0299580. PubMedAbstract available
BAHCACI U, Atasavun Uysal S, Erdogan Iyigun Z, Ordu C, et al Progressive relaxation training in patients with breast cancer receiving
aromatase inhibitor therapy-randomized controlled trial.
PLoS One. 2024;19:e0301020. PubMedAbstract available
ABIDI O, Abdelkafi-Koubaa Z, Bettaieb-Dridi I, Toumi L, et al Pistacia lentiscus L. revealed in vitro anti-proliferative activity on MCF-7
breast cancer cells and in vivo anti-mammary cancer effect on C57BL/6 mice
through necrosis, anti-inflammatory and antioxidant enhancements.
PLoS One. 2024;19:e0301524. PubMedAbstract available
ERDOGAN C, Suer I, Kaya M, Ozturk S, et al Bioinformatics analysis of the potentially functional circRNA-miRNA-mRNA network
in breast cancer.
PLoS One. 2024;19:e0301995. PubMedAbstract available
ALLANA A, Shamsi U, Rashid Y, Khan FR, et al Oral mucositis & oral health related quality of life in women undergoing
chemotherapy for breast cancer in Karachi, Pakistan: A multicenter hospital based
cross-sectional study.
PLoS One. 2024;19:e0295456. PubMedAbstract available
EUM DY, Jeong M, Park SY, Kim J, et al AM-18002, a derivative of natural anmindenol A, enhances radiosensitivity in
mouse breast cancer cells.
PLoS One. 2024;19:e0296989. PubMedAbstract available
KIM BK, Kim B, You SH, Jang MS, et al Early therapy evaluation of intra-arterial trastuzumab injection in a human
breast cancer xenograft model using multiparametric MR imaging.
PLoS One. 2024;19:e0300171. PubMedAbstract available
LUKASIEWICZ-SMIETANSKA D, Godlewski D, Nowakowska E, Szpak A, et al Association of the bitter taste genes TAS2R38 and CA6 and breast cancer risk; a
case-control study of Polish women in Poland and Polish immigrants in USA.
PLoS One. 2024;19:e0300061. PubMedAbstract available
LEVKOVICH I, Rosman L, Signorelli C "Hearing the pupils' voices through my own struggles": A qualitative study of
return to work among school counselors who are breast cancer survivors.
PLoS One. 2024;19:e0300396. PubMedAbstract available
BEHR M, Alizadeh L, Buckner-Baiamonte L, Roberts B, et al Structured illumination microscopy for cancer identification in diagnostic breast
biopsies.
PLoS One. 2024;19:e0302600. PubMedAbstract available
VERMEHREN-SCHMAEDICK A, Peto M, Wagoner W, Chiotti KE, et al Mutation of SIVA, a candidate metastasis gene identified from clonally related
bilateral breast cancers, promotes breast cancer cell spread in vitro and in
vivo.
PLoS One. 2024;19:e0302856. PubMedAbstract available
KAWAZU M, Saso K, Tong KI, McQuire T, et al Correction: Histone Demethylase JMJD2B Functions as a Co-Factor of Estrogen
Receptor in Breast Cancer Proliferation and Mammary Gland Development.
PLoS One. 2024;19:e0303780. PubMedAbstract available
SCHWARZ F, Arefian H, Hartmann M, Runnebaum I, et al Correction: Cost-effectiveness of talazoparib for patients with locally advanced
or metastasized breast cancer in Germany.
PLoS One. 2024;19:e0303776. PubMedAbstract available
SUN G, Cai L, Yan X, Nie W, et al A prediction model based on digital breast pathology image information.
PLoS One. 2024;19:e0294923. PubMedAbstract available
PELICANO AC, Goncalves MCT, Castela T, Orvalho ML, et al Repository of MRI-derived models of the breast with single and multiple benign
and malignant tumors for microwave imaging research.
PLoS One. 2024;19:e0302974. PubMedAbstract available
YANG Z, Wang Y, Huang S, Geng Y, et al Identification of potential anti-tumor targets and mechanisms of HuaChanSu
injection using network pharmacology and cytological experiments in Breast
cancer.
PLoS One. 2024;19:e0303650. PubMedAbstract available
PINTO-CARBO M, Vanaclocha-Espi M, Ibanez J, Martin-Pozuelo J, et al Interaction of sedentary behaviour and educational level in breast cancer risk.
PLoS One. 2024;19:e0300349. PubMedAbstract available
SAITO N, Matsuo T, Tsuda H, Yokota H, et al Novel approach to HER2 quantification using phosphor-integrated dots in human
breast invasive cancer microarray.
PLoS One. 2024;19:e0303614. PubMedAbstract available
XIAO J, Tan L, Pei Y, Yang R, et al Association between red cell distribution width and all-cause mortality in
patients with breast cancer: A retrospective analysis using MIMIC-IV 2.0.
PLoS One. 2024;19:e0302414. PubMedAbstract available
MUNTER-YOUNG R, Fuentes-Alburo A, DiGregorio N, Neeser K, et al Clinical and economic outcomes of adding [18F]FES PET/CT in estrogen receptor
status identification in metastatic and recurrent breast cancer in the US.
PLoS One. 2024;19:e0302486. PubMedAbstract available
XU Y, Yu J, Shen R, Shan X, et al Comparison efficacy and safety of acupuncture and moxibustion therapies in breast
cancer-related lymphedema: A systematic review and network meta-analysis.
PLoS One. 2024;19:e0303513. PubMedAbstract available
LUU TNN, Dinh DX, Tran TX, Tran TB, et al Health-state utility of patients with HER2-positive breast cancer in Vietnam: A
multicenter cross-sectional study.
PLoS One. 2024;19:e0303011. PubMedAbstract available
KIM SM, Park N, Park HB, Lee J, et al Exploring novel immunotherapy biomarker candidates induced by cancer deformation.
PLoS One. 2024;19:e0303433. PubMedAbstract available
KHOIRUNNISA SM, Suryanegara FDA, Setiawan D, Postma MJ, et al Economic evaluation of trastuzumab in HER2-positive early breast cancer in
Indonesia: A cost-effectiveness analysis.
PLoS One. 2024;19:e0304483. PubMedAbstract available
RAN T, Chen J, She Q, Mu Y, et al Anthracycline-induced arrhythmias in breast cancer therapy: A meta-analysis of
single-arm trials.
PLoS One. 2024;19:e0303208. PubMedAbstract available
OKYERE ASANTE PG, Owusu AY, Oppong JR, Amegah KE, et al An assessment of the direct and indirect costs of breast cancer treatment in
leading cancer hospitals in Ghana.
PLoS One. 2024;19:e0301378. PubMedAbstract available
JOHNSON KJ, O'Connell CP, Waken RJ, Barnes JM, et al Impact of COVID-19 pandemic on breast cancer screening in a large midwestern
United States academic medical center.
PLoS One. 2024;19:e0303280. PubMedAbstract available
PRAMANIK P, Roy A, Cuevas E, Perez-Cisneros M, et al DAU-Net: Dual attention-aided U-Net for segmenting tumor in breast ultrasound
images.
PLoS One. 2024;19:e0303670. PubMedAbstract available
FU Y, Zhou J, Li J Diagnostic performance of ultrasound-based artificial intelligence for predicting
key molecular markers in breast cancer: A systematic review and meta-analysis.
PLoS One. 2024;19:e0303669. PubMedAbstract available
ALASMARI A Achillea fragrantissima (Forssk.) Sch.Bip instigates the ROS/FADD/c-PARP
expression that triggers apoptosis in breast cancer cell (MCF-7).
PLoS One. 2024;19:e0304072. PubMedAbstract available
ZHOU K, Robert M, Seegers V, Blanc-Lapierre A, et al Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A
multicenter study.
PLoS One. 2024;19:e0304556. PubMedAbstract available
ELGHOROURY EA, Abdelghafar EE, Kamel S, Awadallah E, et al Dysregulation of miR-122, miR-574 and miR-375 in Egyptian patients with breast
cancer.
PLoS One. 2024;19:e0298536. PubMedAbstract available
KALSOOM A, Altaf A, Sattar H, Maqbool T, et al Gene expression and anticancer evaluation of Kigelia africana (Lam.) Benth.
Extracts using MDA-MB-231 and MCF-7 cell lines.
PLoS One. 2024;19:e0303134. PubMedAbstract available
CONZ L, Jales RM, Doria MT, Melloni I, et al Predictive value of ultrasound doppler parameters in neoadjuvant chemotherapy
response of breast cancer: Prospective comparison with magnetic resonance and
mammography.
PLoS One. 2024;19:e0302527. PubMedAbstract available
TSENG TH, Chiang SC, Hsu JC, Ko Y, et al Cost-effectiveness analysis of granulocyte colony-stimulating factors for the
prophylaxis of chemotherapy-induced febrile neutropenia in patients with breast
cancer in Taiwan.
PLoS One. 2024;19:e0303294. PubMedAbstract available
TUTUIANU A, Anene CA, Shelton M, Speirs V, et al Platelet-derived microvesicles isolated from type-2 diabetes mellitus patients
harbour an altered miRNA signature and drive MDA-MB-231 triple-negative breast
cancer cell invasion.
PLoS One. 2024;19:e0304870. PubMedAbstract available
DAVIDOVIC M, Dhokotera T, Dos-Santos-Silva I, Bohlius J, et al Breast cancer in women by HIV status: A report from the South African National
Cancer Registry.
PLoS One. 2024;19:e0305274. PubMedAbstract available
ALEM T, Nigatu D, Birara A, Fetene T, et al Quality of life of breast cancer patients in Amhara region, Ethiopia: A
cross-sectional study.
PLoS One. 2024;19:e0305263. PubMedAbstract available
REY-VARGAS L, Bejarano-Rivera LM, Serrano-Gomez SJ Genetic ancestry is related to potential sources of breast cancer health
disparities among Colombian women.
PLoS One. 2024;19:e0306037. PubMedAbstract available
SAMMAN N, Mohabatkar H, Behbahani M, Ganjlikhani Hakemi M, et al Bioinformatics design of a peptide vaccine containing sarcoma antigen NY-SAR-35
epitopes against breast cancer and evaluation of its immunological function in
BALB/c mouse model.
PLoS One. 2024;19:e0306117. PubMedAbstract available
TSUTSUMI E, Macy AM, LoBello J, Hastings KT, et al Tumor immune microenvironment permissive to metastatic progression of
ING4-deficient breast cancer.
PLoS One. 2024;19:e0304194. PubMedAbstract available
GODINA C, Khazaei S, Belting M, Vallon-Christersson J, et al High Caveolin-1 mRNA expression in triple-negative breast cancer is associated
with an aggressive tumor microenvironment, chemoresistance, and poor clinical
outcome.
PLoS One. 2024;19:e0305222. PubMedAbstract available
DONG J, Wang D, Zhong S Effects of different exercise types and cycles on pain and quality of life in
breast cancer patients: A systematic review and network meta-analysis.
PLoS One. 2024;19:e0300176. PubMedAbstract available
LI X, Niu C, Yi G, Zhang Y, et al Quercetin inhibits the epithelial-mesenchymal transition and reverses CDK4/6
inhibitor resistance in breast cancer by regulating circHIAT1/miR-19a-3p/CADM2
axis.
PLoS One. 2024;19:e0305612. PubMedAbstract available
AHMAD J, Akram S, Jaffar A, Ali Z, et al Deep learning empowered breast cancer diagnosis: Advancements in detection and
classification.
PLoS One. 2024;19:e0304757. PubMedAbstract available
JENKINS V, Habibi R, Hall V, Leonard P, et al Roll-out of an educational workshop to improve knowledge and self-confidence of
healthcare professionals engaged in mainstreaming of breast cancer genetics.
PLoS One. 2024;19:e0307301. PubMedAbstract available
GEREMEW H, Golla EB, Simegn MB, Abate A, et al Late-stage diagnosis: The driving force behind high breast cancer mortality in
Ethiopia: A systematic review and meta-analysis.
PLoS One. 2024;19:e0307283. PubMedAbstract available
WANG X, Dai Z, Zhu X, Li Y, et al Effects of mindfulness-based stress reduction on quality of life of breast cancer
patient: A systematic review and meta-analysis.
PLoS One. 2024;19:e0306643. PubMedAbstract available
MON AM, Craig MacKinnon A Jr, Traktman P Correction: Overexpression of the VRK1 kinase, which is associated with breast
cancer, induces a mesenchymal to epithelial transition in mammary epithelial
cells.
PLoS One. 2024;19:e0307693. PubMedAbstract available
PATRA A, Ali SS, Devi NM, Qadeer AS, et al Prevalence of BRCA mutation in breast and ovarian cancer among women in India: A
systematic review and meta-analysis protocol.
PLoS One. 2024;19:e0306612. PubMedAbstract available
JUNG M, Nicholas N, Grindrod S, Dritschilo A, et al Dual-targeting class I HDAC inhibitor and ATM activator, SP-1-303, preferentially
inhibits estrogen receptor positive breast cancer cell growth.
PLoS One. 2024;19:e0306168. PubMedAbstract available
KAMBALAPALLI S, Baral N, Paul TK, Upreti P, et al Thirty-day hospital readmission in females with acute heart failure and breast
cancer: A retrospective cohort study from national readmission database.
PLoS One. 2024;19:e0301596. PubMedAbstract available
BAENA-MIRET S, Reverter F, Vegas E A framework for block-wise missing data in multi-omics.
PLoS One. 2024;19:e0307482. PubMedAbstract available
PATI A, Panigrahi A, Parhi M, Giri J, et al Performance assessment of hybrid machine learning approaches for breast cancer
and recurrence prediction.
PLoS One. 2024;19:e0304768. PubMedAbstract available
GALIN M, de Girolamo L, Clarisse B, Segura-Djezzar C, et al Exploration of effects of galvanic vestibular stimulation on circadian rhythms
and its associations with sleep and spatial memory in patients with breast
cancer: The ICANSLEEP-2 protocol.
PLoS One. 2024;19:e0306462. PubMedAbstract available
SAJJADI SF, Salehi N, Sadeghi M Comprehensive integrated single-cell RNA sequencing analysis of brain metastasis
and glioma microenvironment: Contrasting heterogeneity landscapes.
PLoS One. 2024;19:e0306220. PubMedAbstract available
BAZIYAR MA, Hosseini A, Jandel F The role of palbociclib on the alterations in CDKN2, CCNE1, E2F3, MDM2
expressions as target genes of miR-141.
PLoS One. 2024;19:e0306545. PubMedAbstract available
VAHED SZ, Khatibi SMH, Saadat YR, Emdadi M, et al Introducing effective genes in lymph node metastasis of breast cancer patients
using SHAP values based on the mRNA expression data.
PLoS One. 2024;19:e0308531. PubMedAbstract available
JOO Y, Kim MJ, Yoon JH, Rho M, et al Second breast cancer following negative breast MRI: Analysis by interval from
surgery and risk factors.
PLoS One. 2024;19:e0306828. PubMedAbstract available
EL HAJI H, Sbihi N, Guermah B, Souadka A, et al Epidemiological breast cancer prediction by country: A novel machine learning
approach.
PLoS One. 2024;19:e0308905. PubMedAbstract available
SIEBERS CCN, Appelman L, Koco L, Palm M, et al Patients' perceptions of targeted breast ultrasound and digital breast
tomosynthesis in the diagnostic setting: A mixed methods study.
PLoS One. 2024;19:e0308840. PubMedAbstract available
PRICE MD, Mali ME, Ernest A, Abrahams AOD, et al Availability and geographic access to breast cancer pathology services in Ghana.
PLoS One. 2024;19:e0305901. PubMedAbstract available
FLEMING L, Zibaite S, Kyle SD, Boyd K, et al Insomnia prehabilitation in newly diagnosed breast cancer patients: Protocol for
a pilot, multicentre, randomised controlled trial comparing nurse delivered sleep
restriction therapy to sleep hygiene education (INVEST trial).
PLoS One. 2024;19:e0305304. PubMedAbstract available
CHOW KM, Chan CWH, Choi KC, McCarthy AL, et al A multimodal couple-coping intervention for enhancing sexual adjustment among
breast cancer women: Study protocol for a randomised controlled trial.
PLoS One. 2024;19:e0309218. PubMedAbstract available
ALNOWAISER K, Saber A, Hassan E, Awad WA, et al An optimized model based on adaptive convolutional neural network and grey wolf
algorithm for breast cancer diagnosis.
PLoS One. 2024;19:e0304868. PubMedAbstract available
BASHIR I, Dilshad E A comparative study of Mentha longifolia var. asiatica and Zygophyllum arabicum
ZnO nanoparticles against breast cancer targeting Rab22A gene.
PLoS One. 2024;19:e0308982. PubMedAbstract available
VIVES N, Vidal C, de Guzman EN, Farre A, et al The use of text messages as an alternative invitation method for breast cancer
screening: A randomized controlled trial (M-TICS study).
PLoS One. 2024;19:e0306720. PubMedAbstract available
AB MUMIN N, Ramli Hamid MT, Wong JHD, Chiew SF, et al Investigation of breast cancer molecular subtype in a multi-ethnic population
using MRI.
PLoS One. 2024;19:e0309131. PubMedAbstract available
PINELLI M, Gerardi C, Lettieri E, Maioru M, et al Comparison of Indocyanine Green with conventional tracers for sentinel lymph node
biopsy in breast cancer: A multidisciplinary evaluation of clinical
effectiveness, safety, organizational and economic impact.
PLoS One. 2024;19:e0309336. PubMedAbstract available
ODONGO D, Musisi A, Okello RO, Bongomin F, et al National diagnostic reference levels for digital diagnostic and screening
mammography in Uganda.
PLoS One. 2024;19:e0294541. PubMedAbstract available
THAO DT, Thanh NP, Quyen DV, Khai LT, et al Identification of breast cancer-associated PIK3CA H1047R mutation in blood
circulation using an asymmetric PCR assay.
PLoS One. 2024;19:e0309209. PubMedAbstract available
BAGHERMANESH SS, Barati M, Hosseini A The effect of ribociclib on the expression levels of miR-141 and CDK4/6-USP51
signaling pathway genes in MCF-7 and MDA-MB-231 cells.
PLoS One. 2024;19:e0309289. PubMedAbstract available
TORRES S, Bayoumi AM, Abrahao ABK, Trudeau M, et al Implementing routine collection of EQ-5D-5L in a breast cancer outpatient clinic.
PLoS One. 2024;19:e0307225. PubMedAbstract available
WATABE S, Watanabe T, Yada S, Aramaki E, et al Exploring a method for extracting concerns of multiple breast cancer patients in
the domain of patient narratives using BERT and its optimization by domain
adaptation using masked language modeling.
PLoS One. 2024;19:e0305496. PubMedAbstract available
GUERRIERI-GONZAGA A, Serrano D, Gnagnarella P, Johansson H, et al Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT
study): Study protocol of a randomized phase II biomarker trial in women at
increased risk for breast cancer.
PLoS One. 2024;19:e0309511. PubMedAbstract available
VAN STRIEN-KNIPPENBERG IS, Timmermans DRM, Engelhardt EG, Konings IRHM, et al Presenting decision-relevant numerical information to Dutch women aged 50-70 with
varying levels of health literacy: Case example of adjuvant systemic therapy for
breast cancer.
PLoS One. 2024;19:e0309668. PubMedAbstract available
AMBRIZ-BARRERA F, Rojas-Jimenez E, Diaz-Velasquez CE, De-La-Cruz-Montoya AH, et al Mutational spectrum of breast cancer by shallow whole-genome sequencing of cfDNA
and tumor gene panel analysis.
PLoS One. 2024;19:e0308176. PubMedAbstract available
AYOUB NM, Sardiah S, Al-Share QY, Alkader MS, et al Exploring angiogenic pathways in breast cancer: Clinicopathologic correlations
and prognostic implications based on gene expression profiles from a large-scale
genomic dataset.
PLoS One. 2024;19:e0310557. PubMedAbstract available
KWAN ML, Pimentel N, Izano M, Iribarren C, et al Adherence to cardiovascular medications and risk of cardiovascular disease in
breast cancer patients: A causal inference approach in the Pathways Heart Study.
PLoS One. 2024;19:e0310531. PubMedAbstract available
HAN M, Chen H, Li J, Zheng X, et al Correlation between symptom experience and fear of cancer recurrence in
postoperative breast cancer patients undergoing chemotherapy in China: A
cross-sectional study.
PLoS One. 2024;19:e0308907. PubMedAbstract available
HINDMARCH S, Gorman L, Usher-Smith JA, Woof VG, et al Development of a breast cancer risk assessment and primary prevention pathway for
women aged 30-39 years: Views of UK primary care providers on the role of primary
care.
PLoS One. 2024;19:e0308638. PubMedAbstract available
KANEDA Y, Yamashita E, Saito H, Gonda K, et al Increasing trends of pharmaceutical payments to breast cancer specialists in
Japan: A retrospective study from 2016 to 2019.
PLoS One. 2024;19:e0310880. PubMedAbstract available
LU Q, Lun D, Dawkins-Moultin L, Li Y, et al Study protocol for writing to heal: A culturally based brief expressive writing
intervention for Chinese immigrant breast cancer survivors.
PLoS One. 2024;19:e0309138. PubMedAbstract available
CHEN Q, Weng Z, Lu Y, Jia Y, et al Correction: An Experimental Analysis of the Molecular Effects of Trastuzumab
(Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on
Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.
PLoS One. 2024;19:e0311128. PubMedAbstract available
ALI M, Wu T, Hu H, Mahmood T, et al Breast tumor segmentation using neural cellular automata and shape guided
segmentation in mammography images.
PLoS One. 2024;19:e0309421. PubMedAbstract available
RAHPEIMA R, Lin CA A comprehensive numerical procedure for high-intensity focused ultrasound
ablation of breast tumour on an anatomically realistic breast phantom.
PLoS One. 2024;19:e0310899. PubMedAbstract available
SHIN E, Kim HM, Koo JS Expression of PD-L1 in breast invasive lobular carcinoma.
PLoS One. 2024;19:e0309170. PubMedAbstract available
SUTHERLAND EK, Smith JD, Ofori-Boateng M, Kushitor SB, et al Study protocol for the development of a real-time interface showing the
availability of breast and cervical cancer services in Ghana.
PLoS One. 2024;19:e0312150. PubMedAbstract available
LI B, Li X, Liu J, Gao Y, et al Immunocyte phenotype and breast cancer risk: A Mendel randomization analysis.
PLoS One. 2024;19:e0311172. PubMedAbstract available
FIRATLIGIL-YILDIRIR B, Bati-Ayaz G, Nonappa, Pesen-Okvur D, et al Invasion/chemotaxis- and extravasation-chip models for breast cancer bone
metastasis.
PLoS One. 2024;19:e0309285. PubMedAbstract available
YU H, Peng Z, Li X, Zhang Y, et al Establishment of a tumor-associated fibroblast associated gene score based on
scRNA-seq to predict prognosis in patients with triple-negative breast cancer.
PLoS One. 2024;19:e0311801. PubMedAbstract available
AL-ATIYYAT N, Salem HF, Hamam AHM Impact of pain on functional status and quality of life in Jordanian women with
breast cancer.
PLoS One. 2024;19:e0307271. PubMedAbstract available
ADDISU S, Bekele A, Seifu D, Assefa M, et al Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor A
(VEGF-A) expressions in Ethiopian female breast cancer and their association with
histopathologic features.
PLoS One. 2024;19:e0308411. PubMedAbstract available
LEE MK, Levine NT, Hayes LR, Shields CG, et al Navigating the cancer care continuum: A comparative study of Black and White
breast cancer patients.
PLoS One. 2024;19:e0312547. PubMedAbstract available
WU Y, Miller ME, Gilmore HL, Thompson CL, et al Epigenetic aging differentially impacts breast cancer risk by self-reported race.
PLoS One. 2024;19:e0308174. PubMedAbstract available
OHKAWA K, Nakabori T, Mukai K, Kozumi K, et al Clinical validation of the suppressive impact of letrozole on liver fibrosis in
patients with breast cancer undergoing continuous letrozole administration: A
retrospective study.
PLoS One. 2024;19:e0311930. PubMedAbstract available
KAUTZ-FREIMUTH S, Lautz Z, Shukri A, Redaelli M, et al Decisional conflict and knowledge in women with BRCA1/2 pathogenic variants: An
exploratory age group analysis of a randomised controlled decision aid trial.
PLoS One. 2024;19:e0311432. PubMedAbstract available
PANDIYAN A, Lari S, Vanka J, Kumar BS, et al Plasma pesticide residues-serum 8-OHdG among farmers/non-farmers diagnosed with
lymphoma, leukaemia and breast cancers: A case-control study.
PLoS One. 2024;19:e0295625. PubMedAbstract available
ANH NK, Lee A, Phat NK, Yen NTH, et al Combining metabolomics and machine learning to discover biomarkers for
early-stage breast cancer diagnosis.
PLoS One. 2024;19:e0311810. PubMedAbstract available
MING Y, Yang F, Xiao Y, Yue S, et al Exploring the feasibility of FOCUS DWI with deep learning reconstruction for
breast cancer diagnosis: A comparative study with conventional DWI.
PLoS One. 2024;19:e0313011. PubMedAbstract available
KIM JW, Bae SH, Moon Y, Kim EK, et al Transcriptomic analysis of cellular senescence induced by ectopic expression of
ATF6alpha in human breast cancer cells.
PLoS One. 2024;19:e0309749. PubMedAbstract available
SILVA MA, Williams S, Hauert S, Ovadia B, et al Tumour assessment of ROR1 levels in various adult leukaemia and lymphoma types.
PLoS One. 2024;19:e0313026. PubMedAbstract available
TIBENDERANA JR, Kessy SA, Mlaponi DF, Mwaitete NL, et al Predictors of breast cancer screening among women of reproductive age in
Tanzania: Evidence from DHS 2022.
PLoS One. 2024;19:e0298996. PubMedAbstract available
ZHANG H, Liang H, Wenjia G, Jing M, et al ACL-DUNet: A tumor segmentation method based on multiple attention and densely
connected breast ultrasound images.
PLoS One. 2024;19:e0307916. PubMedAbstract available
LAI H, Liu Y, Gong Y, Zong C, et al Expression of SIGLEC15 correlates with tumor immune infiltration, molecular
subtypes, and breast cancer progression.
PLoS One. 2024;19:e0313561. PubMedAbstract available
BAWALLE AA, Nguyen TXT, Khan MSR, Kadoya Y, et al Impact of financial literacy and education on breast and cervical cancer
screening participation in Japan.
PLoS One. 2024;19:e0313687. PubMedAbstract available
MULUGETA C, Emagneneh T, Kumie G, Ejigu B, et al Delayed presentation of breast cancer patients and contributing factors in East
Africa: Systematic review and meta-analysis.
PLoS One. 2024;19:e0309792. PubMedAbstract available
FIGALLO M, Delgado MF, Gonzalez M, Arenas A, et al Cost minimization analysis of treatments for metastatic HER2-positive breast
cancer in Peru: Fixed-dose combination of pertuzumab and trastuzumab for
subcutaneous injections.
PLoS One. 2024;19:e0295730. PubMedAbstract available
CHUTOE C, Inson I, Krobthong S, Phueakphud N, et al Combinatorial effects of cannabinoid receptor 1 and 2 agonists on characteristics
and proteomic alteration in MDA-MB-231 breast cancer cells.
PLoS One. 2024;19:e0312851. PubMedAbstract available
SONG W, Shari NI, Song J, Zhang R, et al Effectiveness of Acceptance and Commitment Therapy (ACT) on disease acceptance
for breast cancer patients: Study protocol of a randomized controlled trial.
PLoS One. 2024;19:e0312669. PubMedAbstract available
ZILENAITE-PETRULAITIENE D, Rasmusson A, Valkiuniene RB, Laurinaviciene A, et al Spatial distributions of CD8 and Ki67 cells in the tumor microenvironment
independently predict breast cancer-specific survival in patients with ER+HER2-
and triple-negative breast carcinoma.
PLoS One. 2024;19:e0314364. PubMedAbstract available
ADHAM SA, Al Kalbani A, Al Zeheimi N, Al Dalali M, et al Glycemic load impacts the response of acquired resistance in breast cancer cells
to chemotherapeutic drugs in vitro.
PLoS One. 2024;19:e0311345. PubMedAbstract available
FANIZZI A, Bove S, Comes MC, Di Benedetto EF, et al Prediction of breast cancer Invasive Disease Events using transfer learning on
clinical data as image-form.
PLoS One. 2024;19:e0312036. PubMedAbstract available
BOTELHO R, Kirstein CL, Philpot RM Cyclophosphamide- and doxorubicin-induced impairment of high affinity choline
uptake and spatial memory can be prevented by dietary choline supplementation in
breast tumor bearing mice.
PLoS One. 2024;19:e0305365. PubMedAbstract available
HSU SN, Hui EWE, Liu M, Wu D, et al Correction: Revealing nuclear receptor hub modules from Basal-like breast cancer
expression networks.
PLoS One. 2024;19:e0314424. PubMedAbstract available
CHANG CH, Lee YC, Huang CW, Lu YM, et al Is tamoxifen good enough for the Asian population in ER+ HER2- post-menopausal
women with early breast cancer? A nationwide population-based cohort study.
PLoS One. 2024;19:e0313120. PubMedAbstract available
KIBRIA MK, Ali MA, Mollah MNH Exploring bacterial key genes and therapeutic agents for breast cancer among the
Ghanaian female population: Insights from In Silico analyses.
PLoS One. 2024;19:e0312493. PubMedAbstract available
AKINGBADE O, Hong KY, Ayo OS, Alade AS, et al Development and feasibility of an mHealth intervention for psychoeducational
support of Nigerian women diagnosed with breast cancer undergoing chemotherapy: A
pilot randomized controlled trial.
PLoS One. 2024;19:e0314365. PubMedAbstract available
WASSIE M, Zegeye AF, Aemro A, Terefe B, et al Awareness and its determinant factors towards breast examination to detect breast
cancer among reproductive age women in Kenya: Multi level analysis of the recent
demographic and health survey data.
PLoS One. 2024;19:e0314700. PubMedAbstract available
JHA A, Chaudhary RK, Shrivastav S, Khanal U, et al Ultrasonographic and pathological correlation of asymmetric retroareolar density
on mammogram.
PLoS One. 2024;19:e0301180. PubMedAbstract available
LOKTIONOVA MV, Mohammadian M, Choopani R, Kheiri S, et al Investigating the relationship between insulin use and all-cause mortality,
breast cancer mortality, and recurrence risk in diabetic patients with breast
cancer: A comprehensive systematic review and meta-analysis.
PLoS One. 2024;19:e0314565. PubMedAbstract available
Correction: BCR-Net: A deep learning framework to predict breast cancer
recurrence from histopathology images.
PLoS One. 2024;19:e0315419. PubMedAbstract available
CAPAR A, Ekinci DA, Ertano M, Niazi MKK, et al An interpretable framework for inter-observer agreement measurements in TILs
scoring on histopathological breast images: A proof-of-principle study.
PLoS One. 2024;19:e0314450. PubMedAbstract available
DONG F, Li J, Wang J, Yang X, et al Diagnostic performance of DCE-MRI radiomics in predicting axillary lymph node
metastasis in breast cancer patients: A meta-analysis.
PLoS One. 2024;19:e0314653. PubMedAbstract available
SCHRODER AK, Loy CJ, Aiala F, Rafique J, et al miR-379-5p affects breast cancer cell behavior by targeting UBE2E3 ubiquitin
conjugating enzyme.
PLoS One. 2024;19:e0310315. PubMedAbstract available
MENDIVELSO-GONZALEZ DF, Clavijo Cabezas D, Montoya L, Plazas Vargas M, et al HER2-low prevalence among Hispanic/Latino women with breast cancer: A systematic
review and meta-analysis.
PLoS One. 2024;19:e0315287. PubMedAbstract available
BUNNELL A, Hung K, Shepherd JA, Sadowski P, et al BUSClean: Open-source software for breast ultrasound image pre-processing and
knowledge extraction for medical AI.
PLoS One. 2024;19:e0315434. PubMedAbstract available
FANG Q, Fang Q, Cheng R, Feng T, et al CAPE activates AMPK and Foxo3 signaling to induce growth inhibition and
ferroptosis in triple-negative breast cancer.
PLoS One. 2024;19:e0315037. PubMedAbstract available
LEMMA SEIFU B, Mekuria Negussie Y, Abrham Asnake A, Daba Chinkey F, et al Determinants of breast cancer screening among women of reproductive age in
sub-Saharan Africa: A multilevel analysis.
PLoS One. 2024;19:e0312831. PubMedAbstract available
AMER NN, Khairat R, Hammad AM, Kamel MM, et al Correction: DDX43 mRNA expression and protein levels in relation to
clinicopathological profile of breast cancer.
PLoS One. 2024;19:e0316591. PubMedAbstract available
ZHANG W, Huang Y, Zhou Y, Xue J, et al Delving into female breast cancer: Distinct disease-specific survival outcomes
between invasive lobular and ductal carcinomas revealed by propensity score
matching.
PLoS One. 2024;19:e0300116. PubMedAbstract available
TRAN TTQ, Pham TT, Nguyen TT, Hien Do T, et al An appropriate DNA input for bisulfite conversion reveals LINE-1 and Alu
hypermethylation in tissues and circulating cell-free DNA from cancers.
PLoS One. 2024;19:e0316394. PubMedAbstract available
KIM J, Lee J, Kim B, Kim S, et al Generation of deep learning based virtual non-contrast CT using dual-layer
dual-energy CT and its application to planning CT for radiotherapy.
PLoS One. 2024;19:e0316099. PubMedAbstract available